Here are some highlights of what our Osteoarthritis Center research team is doing to help improve arthritis diagnosis and treatment:
Dr. Aliprantis’ basic science group evaluates the molecular pathways
that cause osteoarthritis in animal models, with the goal of securing
new drug targets. His group is also identifying osteoarthritis
biomarkers, a project facilitated by a biorepository and co-managed by
Aliprantis, containing hundreds of clinical samples from osteoarthritis
patients.
Jeffrey Katz, MD, of Rheumatology and Orthopedics is conducting a
multi-center trial to evaluate the efficacy of surgery to trim a torn
meniscus versus non-operative management in patients with concomitant
osteoarthritis.
Elena Losina, MD, of Orthopedics is Principal Investigator of the
Osteoarthritis Policy Model, a computer simulation model that she has
used to project the costs and quality of life associated with
osteoarthritis, concomitant obesity, anterior cruciate ligament tear and
other clinical scenarios.
